Video Interviews With Industry Leaders
The Digital Health Coalition partners with a wide array of pharmaceutical industry leaders and key stakeholders to facilitate and disseminate insights on a range of topics related to digital pharmaceutical marketing innovation.
Recent Short Takes
Mark Bard, with DHC Group, is joined by Louis Naimoli, Programmatic, Haymarket Media, to discuss the state of programmatic advertising including topics such as budgets, education, agency partnerships and what’s ahead for 2023. This discussion also touches on innovations related to medical events and targeting health professional with a deep dive into what’s happening with OOH (out of home) advertising to reach targets on a geographic and location basis. Stay tuned for future updates from DHC Group on programmatic in 2023.
Join Mark Bard, with DHC Group, and Erica Taylor, CMO Genentech, for a discussion on measuring effectiveness of marketing, authentic communication and exchanges with customers, and building successful teams within the organization. Additional topics of discussion include how we can (or should) think about compassion for customers when creating marketing and brands, the difference between engagement and experience, as well as how pharma company leaders can realistically and practically promote change with regard to access to care within underserved patient populations. A brilliant marketing leader and passionate about positive change, Erica sheds light on topics all marketers must understand today.
Mark Bard hosts a Fireside Chat with Jen Alper on her experience and lessons learned in the industry. Having spent almost 15 years with Pfizer – and before that almost 5 years with Lilly – Jen understands sales and marketing and has been at the forefront during a time of massive change in the industry with regard to marketing, digital, and sales engagement.
While many pharma execs gain experience within different parts of commercial operations inside pharma during their career, some have the opportunity and desire to work across the broader health and pharma ecosystem. Meghan Rivera is certainly one of those execs with experience in pharma, agencies, technology and startups in the digital health space. In this wide ranging interview Meghan discusses what she has learned along the way, offering insights to other execs mapping out their own career, and what she sees ahead for women’s health.
Marianne Swift, Director of Client Partnerships at Spotify, joins Mark Bard with DHC Group to evaluate the role of digital audio for today’s healthcare marketer. Together they address the most common questions around audio marketing today, including integration into the existing campaign, the role and sophistication of data, and, of course, brand safety. Marianne also shares her thoughts on “what’s next” for pharma in audio.
Filmed June 2022
In this discussion with Will Febbo, CEO of OptimizeRx, Mark Bard with DHC Group reviews the experiences Will had as an entrepreneur and his early insights that motivated him to explore how we can use technology to improve medicine. Building on his experience with data driven decision making platforms in the market research space, the conversation also touches on how technology can link the pharma industry and medical professionals using digital platforms and the EMR to guide medical care decisions.
Mark Bard talks with Kristi Veitch, EVP of HR at Intouch Group, about the trends around return to work and restarting a cohesive team and office culture. Kristi shares insights on how senior leadership and department leads be effective while being completely remote and how to foster community with a hybrid team.
Mark Bard talks with Peter Kirk, founder of Sermo, about his recent experiences as a founder, patient, and thought leader. The conversation starts with a review of his recent experience with cancer and his decision to run the NYC Marathon shortly after treatment. Peter also provides this thoughts on how physicians are using social media, sharing content, and the opportunity for enhanced engagement as physician utilization continues to increase over time.
This two part conversation with Peter Friedman, founder of LiveWorld, starts with a review of his experience at Atari and then Apple – in the early days of networking and community. Peter discusses the initial drivers of community and what kept users coming back – for content and services.
Following a review of his time with Apple, the conversation moves to his motivation to started LiveWorld and what he sees happening in the near future after a rapid rush to social for physicians on a global basis over the past two years. Looking forward, he discusses how brands and companies can better understand and engage users (and customers) in social.
The explosion of data in health has created opportunities and challenges for companies seeking to better understand how to align their clinical trials, product launch, and ongoing marketing and sales strategies based on real world data. Komodo has pulled data together to help health care companies and life sciences firms understand how to better target, understand, and optimize patient outcomes. This conversation with Web Sun covers recent data trends, how pharma companies can overcome the data to insight challenge, and what’s ahead for real world evidence.
Heidi Anderson Hupe
You can’t talk about the role of digital over the past two years without a conversation about connected care, remote monitoring, and tele-health. When you think of tele-health … you think of Teladoc. Not only have they continued to reinvent the connected care model, they have expanded their reach with acquisitions such as Livongo (care management and monitoring). Learn about where the market is today for patients, physicians, payers, pharma and employers — and where it’s headed in the near future with industry expert Heidi Anderson Hupe.
A conversation with Spencer Curtis about identifying future talent, mentoring future leaders, and preparing the next generation for innovation. The discussion also touches on the role of big tech in digital health, drivers of digital therapeutics, reaching the audiences in most need of digital health solutions, and how pharma companies can partner with innovative companies and startups.
Monique and Mark discuss digital market trends and the current landscape for digital therapeutics. Topics of discussion also include the role of mobile devices in patient health as well as opportunities with patient level data.
Receive exclusive interviews and articles — delivered straight to your inbox every month.